B-cell intrinsic and extrinsic signals that regulate central tolerance of mouse and human B cells.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical and mechanistic studies without original clinical data.
PubMed 34997597 · doi:10.1111/imr.13062
What was done
This narrative review summarizes recent literature on the intrinsic and extrinsic molecular mechanisms governing central tolerance in developing mouse and human B cells, focusing on bone marrow culture systems, mouse models, and the specific contributions of the ERK, PI3K, and CXCR4 signaling pathways.
What was found
The abstract reports no quantitative values or statistical results. It describes the standard biological model wherein non-autoreactive or low-avidity IgM+ immature B cells migrate to the periphery, while medium- to high-avidity autoreactive clones remain in the bone marrow to undergo receptor editing or clonal deletion regulated by ERK, PI3K, and CXCR4 signaling.
Why it matters
Elucidating the pathways controlling central tolerance helps clarify the checkpoint mechanisms that eliminate autoreactive clones before they reach peripheral circulation, informing research into the origins of autoimmune disease.
Limits
This is a narrative review with no systematic search methodology, meta-analytic data, or novel empirical findings. The mechanistic insights rely heavily on in vitro bone marrow cultures and animal models, which may not fully reflect human central tolerance in vivo.
Cited by
- supports B cells generate unique antibodies through random somatic recombination and selection processes before releasing antibodies into the bloodstream.